The 6′-SL and 2′-FL have previously been shown to protect against necrotizing enterocolitis (severity) by reducing inflammation through inhibition of the Toll-like receptor 4 activation pathway (39). This evidence concerns the gene TLR4 and necrotizing enterocolitis.